What question did this study set out to answer?

To evaluate the safety of using immunotherapy during the perioperative period in patients undergoing surgery for spinal metastases.

April 12, 2026

Safety of Perioperative Immunotherapy Use on Wound Healing After Surgery for Spinal Metastases

Key Points

To evaluate the safety of using immunotherapy during the perioperative period in patients undergoing surgery for spinal metastases.
Clinical assessment of wound healing outcomes
Comparison between patients receiving immunotherapy and those not receiving it
Evaluation of surgical planning processes
No major complications in wound healing were observed due to immunotherapy
Immunotherapy is deemed clinically safe during surgical planning for spinal metastases

Abstract

Perioperative immunotherapy use for spinal metastases seems clinically safe without major wound healing implications. These findings suggest immunotherapy can be safely administered to patients during surgical planning for spinal metastases.

Demander à l'IA

Bookmark